The 2024 International Rett Syndrome Foundation (IRSF) Rett Syndrome Scientific Meeting, held in Westminster, Colorado, gathered over 200 researchers and clinicians to discuss advancements in understanding and treating Rett syndrome (RTT). Key topics included MeCP2 biology, neuronal circuitry, therapeutic development, and clinical trial outcomes. The meeting reinforced the importance of collaborative research in unraveling RTT’s complex pathology and advancing treatment approaches. With promising therapeutic candidates in development, the conference underscored a growing hope for effective treatments, offering a path toward improving the quality of life for individuals with Rett syndrome and their families.
RettA. On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr1966; 116(37): 723–726.
2.
HagbergBAicardiJDiasK, et al.A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann Neurol1983; 14(4): 471–479. DOI: 10.1002/ana.410140412.
3.
LeonardHCobbSDownsJ. Clinical and biological progress over 50 years in Rett syndrome. Nat Rev Neurol2017; 13(1): 37–51. DOI: 10.1038/nrneurol.2016.186.
NeulJLKaufmannWEGlazeDG, et al.Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol2010; 68(6): 944–950. DOI: 10.1002/ana.22124.
6.
PercyAKNeulJLGlazeDG, et al.Rett syndrome diagnostic criteria: lessons from the Natural History Study. Ann Neurol2010; 68(6): 951–955. DOI: 10.1002/ana.22154.
7.
NeulJLBenkeTAMarshED, et al.Clinical features and disease progression in older individuals with Rett syndrome. Genes2024; 15(8): 1107. DOI: 10.3390/genes15081107.
8.
PercyAKBenkeTAMarshED, et al.Rett syndrome: The natural history study journey. Annals of the Child Neurology Society2024; 2(3): 189–205. DOI: 10.1002/cns3.20086.
9.
AmirREVan den VeyverIBWanM, et al.Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet1999; 23(2): 185–188. DOI: 10.1038/13810.
10.
NeulJLFangPBarrishJ, et al.Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology2008; 70(16): 1313–1321. DOI: 10.1212/01.wnl.0000291011.54508.aa.
11.
LystMJBirdA. Rett syndrome: a complex disorder with simple roots. Nat Rev Genet2015; 16(5): 261–275. DOI: 10.1038/nrg3897.
12.
PercyAKLaneJAnneseF, et al.When Rett syndrome is due to genes other than MECP2. Transl Sci Rare Dis2018; 3(1): 49–53. DOI: 10.3233/TRD-180021.
13.
NeulJLBenkeTAMarshED, et al.The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2. Am J Med Genet B Neuropsychiatr Genet2019; 180(1): 55–67. DOI: 10.1002/ajmg.b.32707.
14.
AnanthAFuCNeulJL, et al.MECP2 variants in males: more common than previously appreciated. Pediatr Neurol2024; 161: 263–267. DOI: 10.1016/j.pediatrneurol.2024.09.022.
15.
ChahrourMJungSYShawC, et al.MeCP2, a key contributor to neurological disease, activates and represses transcription. Science2008; 320(5880): 1224–1229. DOI: 10.1126/science.1153252.
16.
SkenePJIllingworthRSWebbS, et al.Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell2010; 37(4): 457–468. DOI: 10.1016/j.molcel.2010.01.030.
17.
TillotsonRBirdA. The molecular basis of mecp2 function in the brain. J Mol Biol2020; 432(6): 1602–1623. DOI: 10.1016/j.jmb.2019.10.004.
18.
PejhanSRastegarM. Role of DNA methyl-CpG-binding protein MeCP2 in Rett syndrome pathobiology and mechanism of disease. Biomolecules2021; 11(1): 75. DOI: 10.3390/biom11010075.
19.
OluigboDC. Rett syndrome: A tale of altered genetics, synaptic plasticity, and neurodevelopmental dynamics. Cureus2023; 15(7): e41555. DOI: 10.7759/cureus.41555.
20.
LiuYFlamierABellGW, et al.MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. Neuron2024; 112: 1943–1958.e10. DOI: 10.1016/j.neuron.2024.04.007.
21.
MooreJRNemeraMTD’SouzaRD, et al. Non-CG DNA methylation and MeCP2 stabilize repeated tuning of long genes that distinguish closely related neuron types. bioRxiv2024; 577861. DOI: 10.1101/2024.01.30.577861.
22.
SonnJYKimWIwanaszkoM, et al. MeCP2 interacts with the super elongation complex to regulate transcription. bioRxiv2024; 601446. DOI: 10.1101/2024.06.30.601446.
23.
DongQLiuQLiR, et al.Mechanism and consequence of abnormal calcium homeostasis in Rett syndrome astrocytes. Elife2018; 7. DOI: 10.7554/eLife.33417.
24.
RahnRMYenAChenS, et al.Mecp2 deletion results in profound alterations of developmental and adult functional connectivity. Cerebr Cortex2023; 33(12): 7436–7453. DOI: 10.1093/cercor/bhad050.
25.
CarstensKELustbergDJShaughnessyEK, et al.Perineuronal net degradation rescues CA2 plasticity in a mouse model of Rett syndrome. J Clin Invest2021; 131(16): e137221. DOI: 10.1172/JCI137221.
26.
Whitaker-FornekJRJenkinsPMLevittES. Inhibitory synaptic transmission is impaired in the Kölliker-Fuse of male, but not female, Rett syndrome mice. J Neurophysiol2023; 130(6): 1578–1587. DOI: 10.1152/jn.00327.2023.
27.
QianJGuanXXieB, et al.Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons. Sci Transl Med2023; 15(679): eadd4666. DOI: 10.1126/scitranslmed.add4666.
28.
HalmaiJANMDengPGonzalezCE, et al.Artificial escape from XCI by DNA methylation editing of the CDKL5 gene. Nucleic Acids Res2020; 48(5): 2372–2387. DOI: 10.1093/nar/gkz1214.
29.
VanderplowAMDodisGERheeY, et al.Site-blocking antisense oligonucleotides as a mechanism to fine-tune MECP2 expression. RNA2024; 30: 1554–1571. DOI: 10.1261/rna.080220.124.
30.
SmithMArthurBCikowskiJ, et al.Clinical and preclinical evidence for M1 muscarinic acetylcholine receptor potentiation as a therapeutic approach for Rett syndrome. Neurotherapeutics2022; 19(4): 1340–1352. DOI: 10.1007/s13311-022-01254-3.
31.
SmithMDodisGEVanderplowAM, et al. Potentiation of the M 1 muscarinic acetylcholine receptor normalizes neuronal activation patterns and improves apnea severity in Mecp2+/- mice. bioRxiv2024; 586099. DOI: 10.1101/2024.04.15.586099.
32.
SabyJNBenkeTAPetersSU, et al.Multisite study of evoked potentials in Rett syndrome. Ann Neurol2021; 89(4): 790–802. DOI: 10.1002/ana.26029.
33.
DongH-WWeissKBaughK, et al.Potentiation of the muscarinic acetylcholine receptor 1 modulates neurophysiological features in a mouse model of Rett syndrome. Neurotherapeutics2024; 21: e00384. DOI: 10.1016/j.neurot.2024.e00384.
34.
YueYXuPLiuZ, et al.Motor training improves coordination and anxiety in symptomatic Mecp2-null mice despite impaired functional connectivity within the motor circuit. Sci Adv2021; 7(43): eabf7467. DOI: 10.1126/sciadv.abf7467.
35.
YueYAshRTBoyleN, et al.MeCP2 deficiency impairs motor cortical circuit flexibility associated with motor learning. Mol Brain2022; 15(1): 76. DOI: 10.1186/s13041-022-00965-0.
36.
XuPYueYSuJ, et al.Pattern decorrelation in the mouse medial prefrontal cortex enables social preference and requires MeCP2. Nat Commun2022; 13(1): 3899. DOI: 10.1038/s41467-022-31578-9.
37.
LauBYBKrishnanKHuangZJ, et al.Maternal experience-dependent cortical plasticity in mice is circuit- and stimulus-specific and requires MECP2. J Neurosci2020; 40(7): 1514–1526. DOI: 10.1523/JNEUROSCI.1964-19.2019.
38.
RupertDDPagliaroAHChoeJ, et al.Selective deletion of methyl CpG binding protein 2 from parvalbumin interneurons in the auditory cortex delays the onset of maternal retrieval in mice. J Neurosci2023; 43(40): 6745–6759. DOI: 10.1523/JNEUROSCI.0838-23.
39.
ZlaticSAWernerESurapaneniV, et al.Systemic proteome phenotypes reveal defective metabolic flexibility in Mecp2 mutants. Hum Mol Genet2023; 33(1): 12–32. DOI: 10.1093/hmg/ddad154.
40.
ZlaticSADuongDGadallaKKE, et al.Convergent cerebrospinal fluid proteomes and metabolic ontologies in humans and animal models of Rett syndrome. iScience2022; 25(9): 104966. DOI: 10.1016/j.isci.2022.104966.
41.
SheinermanKDjukicATsivinskyVG, et al.Brain-enriched microRNAs circulating in plasma as novel biomarkers for Rett syndrome. PLoS One2019; 14(7): e0218623. DOI: 10.1371/journal.pone.0218623.
42.
KunwarAAblordeppeyKKMireskandariA, et al.Analytical validation of a novel microrna panel for risk stratification of cognitive impairment. Diagnostics2023; 13(13): 2170. DOI: 10.3390/diagnostics13132170.
43.
GargNZhouZMarshED, et al.IRSF 2023 - Rett Syndrome Scientific Meeting Report. Transl Sci Rare Dis2023; 6(4): 137–150. DOI: 10.3233/TRD-230063.
